Market Snapshot

BSE Sensex: 82735.5 0.29%
BSE 500: 36631.98 0.30%
BSE 200: 11593.22 0.36%
BSE 100: 26762.76 0.33%
BSE BANKEX: 68644.19 0.54%
BSE IT: 31056.34 -0.97%
Nifty 50: 25546.3 0.36%
Nifty 500: 23367.4 0.30%
Nifty 200: 14263.4 0.36%
Nifty 100: 26192.6 0.39%
Nifty Midcap 100: 59367.3 0.24%
Nifty Small 100: 16983.45 -0.22%
Nifty IT: 32014.95 -0.94%
Nifty PSU Bank: 9622.15 1.22%

News:

Texmaco Rail & Engineering for...
VL E-Governance & IT Solutions...
KRN Heat Exchanger and Refrige...
CIE Automotive clocks PAT of R...
Paras Defence gains after buyi...

Caplin Point Laboratories Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

20 Feb 2026 | 01:19 PM

1,688.95

-13.45 (-0.79%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-17.63%

Return (1Y)

Underperformed BSE Healthcare by 24.95%
More Volatile

2.29%

Standard Deviation (1Y)

Higher than BSE Healthcare by 1.4%
Not so consistent

5/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

2,397

1,551

News & Announcements

Caplin Point Laboratories consolidated net profit rises 17.93% in the December 2025 quarter
15 days ago

Caplin Point Laboratories consolidated net profit rises 17.93% in the December 2025 quarter

05 - Feb - 2026 12:00 | 15 days ago

Net profit of Caplin Point Laboratories rose 17.93% to Rs 163.88 crore in the quarter ended December 2025 as against Rs 138.96 crore during the previous quarter ended December 2024. Sales rose 10.10% to Rs 542.77 crore in the quarter ended December 2025 as against Rs 492.96 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 542.77 492.96 10

OPM % 34.94 32.92 -

PBDT 223.17 193.46 15

PBT 203.89 177.26 15

NP 163.88 138.96 18

Powered by Capital Market - Live News
Caplin Point Laboratories to announce Quarterly Result
24 days ago

Caplin Point Laboratories to announce Quarterly Result

27 - Jan - 2026 12:00 | 24 days ago

Caplin Point Laboratories will hold a meeting of the Board of Directors of the Company on 5 February 2026.
Powered by Capital Market - Live News
Caplin Point Laboratories consolidated net profit rises 18.08% in the September 2025 quarter
107 days ago

Caplin Point Laboratories consolidated net profit rises 18.08% in the September 2025 quarter

05 - Nov - 2025 12:00 | 107 days ago

Net profit of Caplin Point Laboratories rose 18.08% to Rs 154.45 crore in the quarter ended September 2025 as against Rs 130.80 crore during the previous quarter ended September 2024. Sales rose 10.54% to Rs 534.04 crore in the quarter ended September 2025 as against Rs 483.10 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 534.04 483.10 11

OPM % 35.42 34.08 -

PBDT 219.40 185.22 18

PBT 201.00 168.46 19

NP 154.45 130.80 18

Powered by Capital Market - Live News
Caplin Point Laboratories standalone net profit declines 2.98% in the September 2025 quarter
107 days ago

Caplin Point Laboratories standalone net profit declines 2.98% in the September 2025 quarter

05 - Nov - 2025 12:00 | 107 days ago

Net profit of Caplin Point Laboratories declined 2.98% to Rs 102.59 crore in the quarter ended September 2025 as against Rs 105.74 crore during the previous quarter ended September 2024. Sales declined 15.75% to Rs 175.18 crore in the quarter ended September 2025 as against Rs 207.93 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 175.18 207.93 -16

OPM % 43.30 47.21 -

PBDT 135.02 141.15 -4

PBT 129.00 134.66 -4

NP 102.59 105.74 -3

Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Caplin Point Laboratories Ltd is trading very close to its 52 Week Low
MF shareholding in Caplin Point Laboratories Ltd has increased by 10.04% since past 3 Months
FII shareholding in Caplin Point Laboratories Ltd has increased by 34.83% since past 1 Year
MF shareholding in Caplin Point Laboratories Ltd has increased by 5.96% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	542.77	492.96	10
OPM %	34.94	32.92	-
PBDT	223.17	193.46	15
PBT	203.89	177.26	15
NP	163.88	138.96	18

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	534.04	483.10	11
OPM %	35.42	34.08	-
PBDT	219.40	185.22	18
PBT	201.00	168.46	19
NP	154.45	130.80	18

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	175.18	207.93	-16
OPM %	43.30	47.21	-
PBDT	135.02	141.15	-4
PBT	129.00	134.66	-4
NP	102.59	105.74	-3

General Notifications

My Notifications

Research Notifications

Caplin Point Laboratories Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

1,688.95 -13.45 (-0.79%)

News & Announcements

Price vs Volume

Stock Trivia

Caplin Point Laboratories Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

1,688.95

-13.45 (-0.79%)